IQVIA Selects Veeva Clinical Operations Applications

Sponsors can access all Veeva clinical solutions through IQVIA while retaining flexibility to choose other clinical technologies.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies. This extends the previously announced EDC partnership.

Together, IQVIA and Veeva bring best-in-class capabilities to clinical research to help customers increase trial speed and efficiency, strengthen site centricity, and make better-informed decisions, ultimately helping get life-changing treatments to patients faster. All Veeva clinical solutions are also available through IQVIA for sponsors who wish to enable a full Veeva technology stack.

“By bringing our companies’ strengths together, we’re giving clinical teams a more connected way to work, built on frictionless integration of our respective technologies,” said Richard Staub, president of Research and Development Solutions at IQVIA. “Just as importantly, customers retain the flexibility to choose the EDC, RTSM, and eCOA technologies and solutions that best meet their needs, including IQVIA’s innovative capabilities.”

“This is an exciting expansion of the partnership IQVIA and Veeva announced last year and the work we have done together since,” said Veeva founder and CEO Peter Gassner. “We are committed to supporting seamless product and services integration for the benefit of our customers and improving access to innovations for patients.”

Join us at the Veeva R&D and Quality Summit on October 20-21 in Boston to learn more.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

About Veeva Systems

Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-Looking Statements

This release contains forward-looking statements regarding Veeva's products, services and the expected benefits from use of our products and services, and forward-looking statements regarding Veeva's partnership with IQVIA and the expected benefits of the partnership. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

IQVIAFIN

View source version on businesswire.com: https://www.businesswire.com/news/home/20261013187834/en/

Kerri Joseph
IQVIA Investor Relations
919-541-3558
kerri.joseph@iqvia.com

Alissa Maupin
IQVIA Media Relations
919-923-6785
alissa.maupin1@iqvia.com

Gunnar Hansen
Veeva Investor Relations
267-460-5839
gunnar.hansen@veeva.com

Maria Scurry
Veeva Media Relations
781-366-7617
maria.scurry@veeva.com

Source: IQVIA

Key Terms

ctms technical

A clinical trial management system is software that organizes and tracks the operational side of medical studies—handling patient enrollment, visit scheduling, data collection, budgets and regulatory paperwork. For investors, it matters because good systems can speed up development, lower costs and reduce the chance of delays or compliance problems—like project-management and filing tools that keep a complex construction project on time and within budget.

etmf technical

An eTMF (electronic Trial Master File) is a secure digital filing cabinet that holds the key documents and records generated during a clinical trial, such as protocols, consent forms, monitoring notes and regulatory correspondence. For investors, a well‑organized eTMF matters because it shows a sponsor can document and defend its trial conduct to regulators and auditors; poor or missing records can delay approvals, create costly setbacks or reduce the value of a drug program.

edc technical

An electronic data capture (EDC) system is software used to collect, store and manage clinical trial information digitally instead of on paper. Think of it as a secure online form and filing cabinet that organizes patient visits, test results and compliance records; faster, cleaner data helps sponsors spot problems sooner, shorten development timelines and reduce regulatory risk. Investors track EDC quality because it can speed trials, cut costs and affect the credibility of trial results.

rtsm technical

RTSM stands for Randomization and Trial Supply Management, a software system used in clinical trials to assign participants to treatment groups and to manage investigational product inventory and shipments. It combines randomization logic (ensuring participants are allocated according to the study’s design and blinding rules) with supply tasks such as forecasting needs, releasing drug shipments to sites, tracking stock levels, and handling returns or resupplies. Because RTSM controls both who receives which treatment and when sites are supplied, it must be validated, auditable, and tightly integrated with enrollment and pharmacy procedures to preserve trial integrity and regulatory compliance.

ecoa technical

Electronic Clinical Outcome Assessment (eCOA) is the use of electronic devices—such as smartphones, tablets, or dedicated handhelds—to collect clinical outcome data directly from patients, caregivers, or clinicians. It covers patient-reported outcomes (symptoms, quality of life), clinician-reported outcomes, and observer-reported outcomes, replacing paper forms with time-stamped digital entries, automated reminders, and built-in logic to improve completeness and data integrity. eCOA systems record how and when answers were given and often include validation, audit trails, and data export features to meet regulatory and audit requirements.